Overview

Fatigue and Interleukin-1 (IL-1) Blockade in Primary Sjøgrens Syndrome

Status:
Completed

Trial end date:
2010-04-01

Target enrollment:

Participant gender:

Summary

Fatigue is a prevalent phenomenon in Primary Sjøgrens syndrome (PSS). Observations indicate that the cytokine IL-1 is of importance for this phenomenon. In this study the investigators block IL-1 by giving Anakinra (an IL-1 receptor antagonist) to patients with PSS.

Phase:

Phase 2

Details

Lead Sponsor:

Helse Stavanger HF

Collaborators:

University of Oslo
University of Stavanger

Treatments:

Interleukin 1 Receptor Antagonist Protein